225 related articles for article (PubMed ID: 26476230)
21. Current concepts and new developments in the treatment of psoriatic arthritis.
Pipitone N; Kingsley GH; Manzo A; Scott DL; Pitzalis C
Rheumatology (Oxford); 2003 Oct; 42(10):1138-48. PubMed ID: 12810935
[TBL] [Abstract][Full Text] [Related]
22. Novel Concepts in Psoriatic Arthritis Management: Can We Treat to Target?
Tucker LJ; Ye W; Coates LC
Curr Rheumatol Rep; 2018 Sep; 20(11):71. PubMed ID: 30229387
[TBL] [Abstract][Full Text] [Related]
23. Psoriatic arthritis: update on pathophysiology, assessment and management.
Mease PJ
Ann Rheum Dis; 2011 Mar; 70 Suppl 1():i77-84. PubMed ID: 21339225
[TBL] [Abstract][Full Text] [Related]
24. Diagnosis and management of psoriatic arthritis.
Balakrishnan C; Madnani N
Indian J Dermatol Venereol Leprol; 2013 Jul; 79 Suppl 7():S18-24. PubMed ID: 23974691
[TBL] [Abstract][Full Text] [Related]
25. Considerations for the definition of remission criteria in psoriatic arthritis.
Mease PJ; Coates LC
Semin Arthritis Rheum; 2018 Jun; 47(6):786-796. PubMed ID: 29566966
[TBL] [Abstract][Full Text] [Related]
26. Psoriatic rheumatism. Inflammatory arthropathy.
Macovei L; Brujbu I
Rev Med Chir Soc Med Nat Iasi; 2014; 118(1):45-51. PubMed ID: 24741774
[TBL] [Abstract][Full Text] [Related]
27. The current status and unmet needs in the management of psoriatic arthritis: Viewpoint from physicians in Taiwan.
Li TH; Liao HT; Huang YF; Shen YC; Chiu YC; Chen WS; Chen MH; Tsai CY; Chang DM
J Formos Med Assoc; 2018 May; 117(5):404-412. PubMed ID: 28552625
[TBL] [Abstract][Full Text] [Related]
28. The Role of Tumor Necrosis Factor-α Blockers in Psoriatic Disease. Therapeutic Options in Psoriatic Arthritis.
Addimanda O; Possemato N; Caruso A; Pipitone N; Salvarani C
J Rheumatol Suppl; 2015 Nov; 93():73-8. PubMed ID: 26523063
[TBL] [Abstract][Full Text] [Related]
29. The comparative immunogenicity of biologic therapy and its clinical relevance in psoriatic arthritis: a systematic review of the literature.
Balsa A; Lula S; Marshall L; Szczypa P; Aikman L
Expert Opin Biol Ther; 2018 May; 18(5):575-584. PubMed ID: 29533116
[TBL] [Abstract][Full Text] [Related]
30. Clinical management of psoriatic arthritis.
Van den Bosch F; Coates L
Lancet; 2018 Jun; 391(10136):2285-2294. PubMed ID: 29893227
[TBL] [Abstract][Full Text] [Related]
31. Psoriatic arthritis: a review.
Amherd-Hoekstra A; Näher H; Lorenz HM; Enk AH
J Dtsch Dermatol Ges; 2010 May; 8(5):332-9. PubMed ID: 20015187
[TBL] [Abstract][Full Text] [Related]
32. The actual role of therapy with traditional disease-modifying antirheumatic drugs in psoriatic arthritis.
Soriano ER
J Rheumatol Suppl; 2012 Jul; 89():67-70. PubMed ID: 22751597
[TBL] [Abstract][Full Text] [Related]
33. Early psoriatic arthritis: short symptom duration, male gender and preserved physical functioning at presentation predict favourable outcome at 5-year follow-up. Results from the Swedish Early Psoriatic Arthritis Register (SwePsA).
Theander E; Husmark T; Alenius GM; Larsson PT; Teleman A; Geijer M; Lindqvist UR
Ann Rheum Dis; 2014 Feb; 73(2):407-13. PubMed ID: 23355078
[TBL] [Abstract][Full Text] [Related]
34. Psoriatic arthritis: treat-to-target.
Kavanaugh A
Clin Exp Rheumatol; 2012; 30(4 Suppl 73):S123-5. PubMed ID: 23078992
[TBL] [Abstract][Full Text] [Related]
35. Treatment strategies for early psoriatic arthritis.
Olivieri I; D'Angelo S; Palazzi C; Padula A
Expert Opin Pharmacother; 2009 Feb; 10(2):271-82. PubMed ID: 19236198
[TBL] [Abstract][Full Text] [Related]
36. Difficult to treat psoriatic arthritis - how should we manage?
Kumthekar A; Ashrafi M; Deodhar A
Clin Rheumatol; 2023 Sep; 42(9):2251-2265. PubMed ID: 37097525
[TBL] [Abstract][Full Text] [Related]
37. Treating to target in psoriatic arthritis: assessing real-world outcomes and optimising therapeutic strategy for adults with psoriatic arthritis-study protocol for the MONITOR-PsA study, a trials within cohorts study design.
Rombach I; Tillett W; Jadon D; Tucker L; Watson M; Francis A; Sinomati Y; Eldridge L; Dritsaki M; Dutton SJ; Al-Mossawi H; Gullick N; Thompson B; Coates LC
Trials; 2021 Mar; 22(1):185. PubMed ID: 33663566
[TBL] [Abstract][Full Text] [Related]
38. Rho-GTPase pathways may differentiate treatment response to TNF-alpha and IL-17A inhibitors in psoriatic arthritis.
Rahmati S; O'Rielly DD; Li Q; Codner D; Dohey A; Jenkins K; Jurisica I; Gladman DD; Chandran V; Rahman P
Sci Rep; 2020 Dec; 10(1):21703. PubMed ID: 33303908
[TBL] [Abstract][Full Text] [Related]
39. Validation of minimal disease activity criteria for psoriatic arthritis using interventional trial data.
Coates LC; Helliwell PS
Arthritis Care Res (Hoboken); 2010 Jul; 62(7):965-9. PubMed ID: 20589696
[TBL] [Abstract][Full Text] [Related]
40. Psoriatic arthritis therapy: NSAIDs and traditional DMARDs.
Nash P; Clegg DO
Ann Rheum Dis; 2005 Mar; 64 Suppl 2(Suppl 2):ii74-7. PubMed ID: 15708943
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
